@article{fa12513ebe8c4332b4af7150400a7c92,
title = "Patatin-Like Phospholipase Domain-Containing 3 and the Pathogenesis and Progression of Pediatric Nonalcoholic Fatty Liver Disease",
author = "Browning, {Jeffrey D.} and Cohen, {Jonathan C.} and Hobbs, {Helen H.}",
note = "Funding Information: Abbreviations:: I148M, substitution of methionine for isoleucine at codon 148; NAFLD, nonalcoholic fatty liver disease; NASH, nonalcoholic steatohepatitis; PNPLA3, patatin-like phospholipase domain-containing 3. Supported by the following National Institutes of Health grants: 5K23DK074396 (to J.D.B.), and RL1HL092550 and PO1HL20948 (to H.H.H., J.C.C.). Address reprint requests to: Helen H. Hobbs, M.D.1,2, Department of Molecular Genetics, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX. E-mail: helen.hobbs@utsouthwestern.edu; fax: 214-648-7539. Copyright VC 2010 by the American Association for the Study of Liver Diseases. Published online in Wiley Online Library (wileyonlinelibrary.com). DOI 10.1002/hep.23946 Potential conflict of interest: Dr. Cohen is a consultant for Amgen and is on the speakers{\textquoteright} bureau of Merck and Pfizer. Dr. Hobbs is a consultant for Pfizer.",
year = "2010",
month = oct,
doi = "10.1002/hep.23946",
language = "English (US)",
volume = "52",
pages = "1189--1192",
journal = "Hepatology",
issn = "0270-9139",
publisher = "John Wiley and Sons Ltd",
number = "4",
}